Clinical trial
A Six Month Double-Blind, Placebo-Controlled Trial Followed by Six Month Open-Label Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.
NCT00346190 is registered in ClinicalTrials.gov with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Six Month Double-Blind, Placebo-Controlled Trial Followed by Six Month Open-Label Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.
- Lead sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- January 31, 2003
- Completion date
- April 30, 2007
- Enrollment
- 10
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.